|

BGB-11417 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Sonrotoclax

Pipeline

Phase 1/2: 1

Top Sponsors

  • BeiGene1

Indications

  • Myelodysplastic/Myeloproliferative Neoplasm1
  • Acute Myeloid Leukemia1
  • Myelodysplastic Syndromes1
  • Cancer1

Duarte, California1 trial

A Study of BGB-11417 in Participants With Myeloid Malignancies

City of Hope National Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.